Notes - Segment Information, Etc.

OncoTherapy Science, Inc. - Filing #7329199

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
610,118,000 JPY
610,118,000 JPY
JPY
427,000 JPY
609,690,000 JPY
9,134,000 JPY
1,125,769,000 JPY
1,134,903,000 JPY
JPY
1,134,903,000 JPY
Transactions with other segments
270,000 JPY
JPY
-270,000 JPY
270,000 JPY
JPY
238,000 JPY
JPY
238,000 JPY
-238,000 JPY
JPY
Other items
Depreciation
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Increase in property, plant and equipment and intangible assets
154,564,000 JPY
154,564,000 JPY
JPY
JPY
154,564,000 JPY
490,000 JPY
1,652,000 JPY
2,142,000 JPY
19,411,000 JPY
21,553,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.